Barrett & Company’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Barrett & Company's OGN Position: Q3 2026 in Review
Barrett & Company reduced its Organon & Co (OGN) stake by 17% in Q3 2026, selling an estimated $314 and leaving 109 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #614.
Barrett & Company first reported a position in OGN in Q3 2022 and has held it in 17 quarters since. The position peaked at $12.8K in Q4 2022. 359 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Barrett & Company held 109 shares of Organon & Co worth $1.49K as of Q3 2026.
- Barrett & Company sold 23 Organon & Co shares in Q3 2026, an estimated $314.
- Organon & Co made up ﹤0.01% of Barrett & Company's portfolio in Q3 2026, its #614 holding.
- Barrett & Company first reported a position in Organon & Co in Q3 2022 and has held it in 17 quarters since.
- Barrett & Company's Organon & Co position peaked at $12.8K in Q4 2022.
- 359 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.